Drug Profile
Research programme: soluble CD14 - Bridge BioResearch
Alternative Names: CD14; sCD14Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Mellitus
- Developer Bridge BioResearch
- Class Proteins
- Mechanism of Action Lipopolysaccharide modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Atherosclerosis; Inflammation; Obesity; Type 2 diabetes mellitus
Most Recent Events
- 20 Jan 2012 Preclinical trials in Atherosclerosis in United Kingdom (unspecified route)
- 20 Jan 2012 Preclinical trials in Inflammation in United Kingdom (unspecified route)
- 20 Jan 2012 Preclinical trials in Obesity in United Kingdom (unspecified route)